hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Boehringer, Gilead Freeze Antiretroviral Prices for Some U.S. Agencies [USA]

Author: Kaiser Daily HIV/AIDS Report [USA], Published on: 5 June 2008

Pharmaceutical companies Boehringer Ingelheim and Gilead Sciences are freezing the prices of their antiretroviral drugs for select agencies in the U.S..."We urge the other drug companies to follow [Boehringer's] and Gilead's lead and to freeze price increases…that keep lifesaving drugs out of reach for those who need them," [AIDS Healthcare Foundation] President Michael Weinstein said…Reponses from Abbott Laboratories, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Pfizer, Roche and Johnson & Johnson subsidiary Tibotec Therapeutics "reiterated the companies' commitment to increasing access but made no specific pledge with regard to" price freezes…

Read the full post here

Related companies: Abbott Laboratories Boehringer Ingelheim Bristol-Myers Squibb Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Pfizer Roche Tibotec (part of Johnson & Johnson)